Founders of biotech company MiRXES were working on the PCR technology well before Covid-19 struck 

Apart from the terms ART, MCO, PPE and WFH plus many others, the Covid-19 pandemic has acquainted the world with the acronym of another medical term: Polymerase Chain Reaction (PCR) test. PCR tests are typically administered to detect genetic material from specific organisms, such as the Sars-Cov 2 virus. 

Interestingly, Singapore’s very first lab equipped with PCR technologies was set up at the National University of Singapore (NUS) in 2000, well before the pandemic. Being the first in the region meant that many people were perplexed over what PCR tests could do. “Everybody was like, ‘this bunch of people are doing something called PCR. Anybody knows what it is?’,” Zhou Lihan, co-founder and CEO of biotech company MiRXES, recalled in a recent interview with The Edge Singapore. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook